5 December 2024 - The medication will initially be offered only to those people with the highest clinical needs. ...
22 November 2024 - Breast cancer charities and patients are “devastated” that the drug Enhertu will not be available in ...
27 November 2024 - The MHRA has approved the medicine flortaucipir (Tauvid), given to adults with memory problems so that doctors ...
20 November 2024 - NICE has published final evidence-based recommendations on the use of fedratinib dihydrochloride monohydrate (Inrebic) for the ...
19 November 2024 - Talks with the makers of Enhertu have ended without agreement, meaning guidance that does not recommend Enhertu ...
18 November 2024 - The MHRA has approved the medicine sparsentan (Filspari) to treat primary immunoglobulin A nephropathy. ...
14 November 2024 - NICE has produced updated guidance on the use of zilucoplan sodium in the NHS in England. ...
16 November 2024 - Shanghai Junshi Biosciences announced that the UK MHRA has approved toripalimab (Loqtorzi) for the treatment of two ...
15 November 2024 - The MHRA has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the Omicron JN.1 ...
14 November 2024 - Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance ...
14 November 2024 - NICE has published final evidence-based recommendations on the use of elafibranor (Iqirvo) for the treatment of ...
13 November 2024 - NICE has published final evidence-based recommendations on the use of teclistamab (Tecvayli) for the treatment of ...
13 November 2024 - Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS ...
13 November 2024 - NICE has published final evidence-based recommendations on the use of alectinib hydrochloride for the adjuvant treatment ...
6 November 2024 - Erdafitinib is the first and only bladder cancer therapy that targets FGFR3 alterations and has been ...